Vimarsana
Biggest News Aggregation in the World

Thermo Ultimate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thermo Ultimate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thermo Ultimate Today - Breaking & Trending Today

Cormica Bradford equipment expansion supporting key client programs - Vimarsana News

Cormica Bradford equipment expansion supporting key client programs

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Toxicity of ZnO quantum dots on human SMMC-7721 cells - Vimarsana News

Toxicity of ZnO quantum dots on human SMMC-7721 cells

ZnO QDs don't affect CCK8 cell viability but disturb intracellular metabolites & proteins at 20 µg/mL. KEGG analyses enrich alcoholism & Cushings pathways.

Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1 - Vimarsana News

Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1

Significance Statement Hematopoietic stem cell transplant (HSCT) is a treatment for certain hemat

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates - Vimarsana News

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Among the most promising therapeutic options for individuals with coronavirus disease 2019 (COVID-19) are monoclonal antibodies (mAbs). In this study, Jones et al . identified, characterized, and tested one such mAb, LY-CoV555, in vitro and in vivo. They found that LY-CoV555 bound to the severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) spike protein and prevented its interaction with angiotensin-converting enzyme 2. Prophylactic treatment with LY-CoV555 protected the upper and lower respiratory tracts of nonhuman primates from becoming infected with SARS-CoV-2. Together, t...